Lamborghini is looking at various digital tools to help hone a driver’s skills on the racetrack, and has previewed one of the more promising options at 2024 CES currently underway in Las Vegas.
The automaker showed a system known as Telemetry X, which takes information from a performance data recorder and combines it with biometric data to provide insight on how to improve lap times.
It also takes things to the next level by putting the driver in contact with a remote driver coach who can provide live feedback and suggestions, using fast 5G connections to ensure the driver coach has access to real-time information.
Telemetry X also includes a digital voice assistant that can provide useful pointers—for example to improve racing lines and braking points—using information gathered from the vehicle’s performance data recorder and the driver’s biometrics.
Lamborghini Telemetry X concept
Key biometric data used includes heart rate, temperature, and breathing, which Lamborghini said provide useful references on how a driver can refine his or her training.
Lamborghini CEO Stephan Winkelmann presented Telemetry X at CES in the company’s new Revuelto supercar. He said at the presentation that such a system is a preview of the connected services Lamborghini customers will be able to experience “in the coming years.”
The V-12 plug-in hybrid supercar is already on sale, priced from just over $600,000. Anyone placing an order today will face a lengthy wait time for delivery as the car’s build slots are already allocated for the next two years.
Mini plans to lean more into the outdoor aesthetic with the Countryman. Head of design,…
Older adults who took part in a short program designed to sharpen how quickly they…
Image credit - Stock photo ID:1028621094 As hotel room rates in Delhi soar to as…
Despite Terence Crawford's retirement, Saul "Canelo" Alvarez is chasing a rematch of their September bout,…
A 1971 Mercedes 600 body sits on a 2024 AMG S63 hybrid platform with 800+…
Three recently released Cochrane reviews conclude that GLP-1 medications, such as Ozempic, can lead to…